AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Bortezomib in South Africa
20 products registered with SAHPRA — 20 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| BORTEZOMIB 3,5 mg EUROLAB | 56/26/0602 | Eurolab (Pty) Ltd | active | 8 Oct 2029 |
| BERTRED 3,5 | 51/26/0714 | Dr ReddyÆs Laboratories (Pty) Ltd | active | 25 Sept 2029 |
| BORTEZOMIB ZYDUS | 54/26/0835.834 | Zydus Healthcare (Pty) Ltd | active | 10 Sept 2029 |
| ZYMIB | 54/26/0834 | Zydus Healthcare (Pty) Ltd | active | 10 Sept 2029 |
| DEVACAD | 54/26/0082.081 | Aurogen South Africa (Pty) Ltd | active | 20 Jun 2028 |
| BETANUZ | 54/26/0081 | Aurogen South Africa (Pty) Ltd | active | 20 Jun 2028 |
| PROTECADE 3,5 mg | 53/26/0178 | Adcock Ingram Critical Care (Pty) Ltd | active | 6 Jun 2028 |
| PROTECADE 1 mg | 53/26/0177 | Adcock Ingram Critical Care (Pty) Ltd | active | 6 Jun 2028 |
| BORTEZOMIB EQUITY | 56/26/0040 | Equity Pharmaceutical (Pty) Ltd | active | 25 Apr 2028 |
| VALTIB 3,5 SOLUTION FOR INJECTION | 56/26/0718 | Accord Healthcare (Pty) Ltd | active | 22 Nov 2027 |
| VALTIB 2,5 SOLUTION FOR INJECTION | 56/26/0717 | Accord Healthcare (Pty) Ltd | active | 22 Nov 2027 |
| MIBLEX | 50/26/0093 | Eurolab (Pty) Ltd | active | 11 Jun 2023 |
| BORTEZOMIB HETERO 3,5 mg | 48/26/0121 | Hetero Drugs South Africa (Pty) Ltd | active | 1 Jan 1900 |
| VALOMA 3,5 | 54/26/0346 | Juno Pharma SA (Pty) Ltd | active | 1 Jan 1900 |
| BERTRED 1 | 55/26/0005 | Dr ReddyÆs Laboratories (Pty) Ltd | active | 1 Jan 1900 |
| BORTRAC 3,5 mg | 50/26/0474 | Activo Health (Pty) Ltd | active | 1 Jan 1900 |
| VALOMA 1 | 54/26/0344 | Juno Pharma SA (Pty) Ltd | active | 1 Jan 1900 |
| VELCADE 1 mg | 43/26/0427 | Janssen Pharmaceutica (Pty) Ltd | active | 1 Jan 1900 |
| VELCADE | A40/26/0005 | Janssen Pharmaceutica (Pty) Ltd | active | 1 Jan 1900 |
| VALOMA 2,5 | 54/26/0345 | Juno Pharma SA (Pty) Ltd | active | 1 Jan 1900 |
Bortezomib — SAHPRA Registration Details
SAHPRA (South Africa) has 20 registered products containing Bortezomib, of which 20 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Bortezomib registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.